KIMBERLY MAROLI: Open Payments
NPI 1194219816 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,861 in 12 payments from 8 companies in 2025. Trend: 2023 $27 · 2024 $419 · 2025 $1,861
Consulting: $1,200Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $700 |
| AstraZeneca UK Limited | 1 | $500 |
| AstraZeneca Pharmaceuticals LP | 2 | $148 |
| Esteve Pharmaceuticals LLC | 1 | $145 |
| Janssen Biotech, Inc. | 1 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $101 |
| Merck Sharp & Dohme LLC | 3 | $88 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
Products named: Lenvima, IMFINZI, Lysodren, ERLEADA, Nubeqa, KEYTRUDA, LYNPARZA, PLUVICTO.
Industry payments across OH — which companies pay providers there.
